Skip to content

Next Phase Newsletter

Life Science Nation Next Phase Newsletter

Home
Hot Mandates
Previous Issues
Podcast
Subscribe

Idata

December 11, 2012 ~ Next Phase Admin

Published by Next Phase Admin

View all posts by Next Phase Admin

Post navigation

‹ PreviousIntro to Life Science Nation – Investor Database

Leave a comment Cancel reply

Δ

Popular Topics

Artificial Intelligence (AI)
Fundraising
Haystack Corner
Hot Mandates
Innovator's Pitch Challenge
Interviews
Longevity & Age-Tech
Partnering
Podcast
Redefining Every Stage Investments (RESI)

Listen to the Podcast

Life Science Nation · Recent Episodes

Top Posts

Hot Investor Mandate: Global Pharmaceutical Partner Seeks Novel Therapeutics and Platform Technologies Through Strategic Collaborations
Why Do 90% of Life Science Startups Fail? Because the Science Never Gets Out of the Way
The Problem Is Not the Science: A Seven-Part Series on De-Risking, Signal, and Investability
Cross-Border Investor Luncheon at RESI Boston 2026
Hot Investor Mandate: Early-Stage VC Firm Invests Up to $20M in Novel, First-In-Class Therapeutics Companies With US and Europe Focus
The Lost Art of Following Up
Surge in Family Offices: Investing in Healthcare
Companies to Watch in 2022
Meet Meki Durakovic: The Hospitality Force Behind Boston’s Culinary Hotspots
Hot Investor Mandate: Single Family Office Invests in Seed to Series C Medical Device Companies, With Strong Interest in Surgical Solutions

Recent Posts

Hot Investor Mandate: Global Pharmaceutical Partner Seeks Novel Therapeutics and Platform Technologies Through Strategic Collaborations
Hot Investor Mandate: VC Firm Invests Exclusively in Differentiated Therapeutics Across All Development Stages, Focusing on USA-Based Companies
Hot Investor Mandate: Cross-Border VC Firm Backs Life Science Companies in High Unmet Need Areas Including CNS, Immuno-Oncology, and More
Hot Investor Mandate: Early-Stage VC Firm Invests Up to $20M in Novel, First-In-Class Therapeutics Companies With US and Europe Focus
Cross-Border Investor Luncheon at RESI Boston 2026

LSN Twitter

Tweets by LSciNation

Follow Next Phase Newsletter on WordPress.com

Contact us

+1 (617) 600-0668

Info@lifesciencenation.com

Archives

Archives

Subscribe

Life Science Nation

RESI Conference Series

Investor Platform Demo

Company Platform Demo

Follow Us

X
LinkedIn

Website Powered by WordPress.com.

Comment
Subscribe Subscribed
- Next Phase Newsletter
- Already have a WordPress.com account? Log in now.

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy